- Knockdown of long non-coding RNA plasmacytoma variant translocation 1 relieves ox-LDL-induced endothelial cell injury through regulating microRNA-30c-5p in atherosclerosis
Geng Li et al, 2022, Bioengineered CrossRef - Sacubitril/valsartan protects against arsenic trioxide induced cardiotoxicity in vivo and in vitro
Zhiqiang Wu et al, 2022 CrossRef - Molecular mechanisms of sacubitril/valsartan in cardiac remodeling
Nor Hidayah Mustafa et al, 2022, Front. Pharmacol. CrossRef - Valsartan in Combination with Tripterygium Glycosides Protects against Chronic Nephritis via the Toll-Like Receptor 4 Pathway
Jiabao Dong et al, 2022, Analytical Cellular Pathology CrossRef - The Role of NF-κB and Bax/Bcl-2/Caspase-3 Signaling Pathways in the Protective Effects of Sacubitril/Valsartan (Entresto) against HFD/STZ-Induced Diabetic Kidney Disease
Mohamed Mohany et al, 2022, Biomedicines CrossRef -
A novel circulating biomarker
lnc‐MALAT1
for acute myocardial infarction: Its relationship with disease risk, features, cytokines, and major adverse cardiovascular events
Ruirui Li et al, 2022, Clinical Laboratory Analysis CrossRef - The history and mystery of sacubitril/valsartan: From clinical trial to the real world
Mingsong Zhang et al, 2023, Front. Cardiovasc. Med. CrossRef - Association of Long Noncoding RNA Expression Signatures with Stress-Induced Myocardial Perfusion Defects
Yu-Chieh Chang et al, 2023, Biomolecules CrossRef - Preventive effect of LCZ696 on hypoxic pulmonary hypertension in rats via regulating the PI3K/AKT signaling pathway
Jie Wang et al, 2023, Pulmonary Pharmacology & Therapeutics CrossRef - Top Five Stories of the Cellular Landscape and Therapies of Atherosclerosis: Current Knowledge and Future Perspectives
Qi Pan et al, 2023, CURR MED SCI CrossRef - LCZ696, an Angiotensin Receptor-Neprilysin Inhibitor, Ameliorates Endothelial Dysfunction in Diabetic C57BL/6 Mice
Uugantsetseg Munkhjargal et al, 2024, JAT CrossRef